<DOC>
	<DOCNO>NCT00971074</DOCNO>
	<brief_summary>The investigator ' objective analyze group patient partial meniscectomy continue knee pain surgery double-blind , randomize prospective study compare use Hylan G-F 20 ( single injection viscosupplementation ) versus placebo injection . The investigator would expect patient receive treatment ( Hylan G-F 20 ) low pain compare patient placebo group ( needle inject knee medication substance inject ) since Hylan G-F 20 show decrease pain arthritic patient .</brief_summary>
	<brief_title>Study Viscosupplementation Treatment Knee Pain After Menisectomy</brief_title>
	<detailed_description>A great majority patient partial menisectomy mechanical symptom well full return function without pain . There sub-group patient find Grade II- III chondromalacia lesion ( deem arthritic ) time surgery persistent generalize `` arthritic-type '' pain despite relief mechanical symptom . To date , publish study analyze treatment well treatment group patient . We would expect patient receive treatment ( Hylan G-F 20 ) low pain compare patient placebo group ( needle inject knee medication substance inject ) since Hylan G-F 20 show decrease pain arthritic patient .</detailed_description>
	<mesh_term>Arthralgia</mesh_term>
	<mesh_term>Hylan</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Age 1860 S/P partial medial and/or lateral partial meniscectomy Preoperative MRI diagnose meniscal tear Diffuse , nonfocal arthroscopically diagnose ICRS Grade II III chondromalacia . ( used determine presence tibiofemoral osteoarthritis ) Baseline VAS pain score 50 80mm . Persistent , generalize knee pain without mechanical symptom Kellgren/Lawrence ( K/L ) grade II III ( use determine presence tibiofemoral osteoarthritis ) Bilateral arthroscopy ( within 6 month pre post initial VAS score . Complete meniscectomy Microfracture ( via drilling , picking , abrade , thermal radiofrequency procedure violate subchondral plate ) Focal chondral lesion visualize arthroscopy focal cartilage procedure ( e.g . ACI , OATS , mosaicplasty , etc ) Concomitant ligamentous injury repair K/L stage I IV Significant Varus Valgus clinical malalignment S/P tibial osteotomy target knee Isolated patellofemoral OA isolate anterior knee pain Prosthetic implant either knee Reinjury time original surgery baseline visit Inflammatory arthritis ( e.g . rheumatoid arthritis , gout , pseudogout ( chondrocalcinosis ) , lupus , etc ) Obesity BMI &gt; 35 ( time initial VAS score NSAIDs opiates within one week baseline randomization trial period Known allergy viscosupplements , know allergy avian , egg feather product Prior Viscosupplementation use ipsilateral knee Oral steroid ( within 4 week initial VAS score ) IA steroid target knee within 6 month Significant medical comorbidities ( e.g . malignancy , hepatic , renal , cardiac , pulmonary , gastrointestinal disease ) judgment investigator Known hip disease Pregnant nursing ( time injection , pregnancy test visit ) Active infection either low extremity past history septic arthritis Venous lymphatic stasis either low extremity Enrolled clinical trial within 3 month baseline Contralateral knee arthritis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Arthralgia</keyword>
	<keyword>Viscosupplementation</keyword>
	<keyword>Knee</keyword>
	<keyword>Menisci , Tibial</keyword>
	<keyword>Surgery , Outpatient</keyword>
</DOC>